Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

ScienceDaily
sciencedaily.com > releases > 2026 > 09 > 260911214306.htm

Scientists discover a hidden switch that shuts down inflammation

51+ min ago   (659+ words) Scientists have uncovered a natural braking system that helps the immune system switch off inflammation and prevent harmful immune cells from building up. Boosting this pathway in people reduced inflammation-related immune changes and sped up pain relief, pointing toward potential…...

Yahoo Finance
finance.yahoo.com > healthcare > articles > fda-clears-cu-anschutz-clinical-191500122.html

FDA Clears CU Anschutz Clinical Trial Using Engineered Immune Cells to Fight Colorectal Cancer

2+ day, 14+ hour ago   (836+ words) CAR T-cells developed at CU Anschutz will target two pathways that help colorectal tumors grow and evade the immune system AURORA, Colo., Sept. 10, 2026 /PRNewswire/ -- The U.S. Food and Drug Administration has granted permission for investigators at the University of Colorado Anschutz…...

BIOENGINEER.ORG
bioengineer.org > chemotherapys-hidden-survivors-lactylation-switch-reveals-how-colorectal-cancer-cells-hide-from-treatment

Chemotherapy’s Hidden Survivors: Lactylation Switch Reveals How

31+ min ago   (667+ words) Colorectal cancer remains one of the deadliest malignancies worldwide, and even the most aggressive chemotherapy regimens can fail in a frustratingly subtle way. Tumors often shrink in response to treatment, yet a small population of cells survives in a quiet,…...

BIOENGINEER.ORG
bioengineer.org > dartunifrac-brings-megascale-computing-to-microbiome-diversity-analysis

DartUniFrac Brings Megascale Computing to Microbiome Diversity Analysis

44+ min ago   (512+ words) Researchers have introduced DartUniFrac, a new software tool designed to carry out UniFrac-based microbiome comparisons at a scale that was previously impractical....

BIOENGINEER.ORG
bioengineer.org > immune-side-effects-may-signal-stronger-tumor-shrinkage-and-longer-survival-in-gastric-cancer

Immune Side Effects May Signal Stronger Tumor Shrinkage and Longer Survival

44+ min ago   (628+ words) When patients with advanced gastric cancer receive immune checkpoint inhibitors, one of the most puzzling phenomena in modern oncology is the apparent paradox that side effects can be good news....

BIOENGINEER.ORG
bioengineer.org > ai-uncovers-hidden-human-protein-that-builds-bridges-between-cells

AI Uncovers Hidden Human Protein That Builds Bridges Between Cells

58+ min ago   (679+ words) For most of modern biology, the hunt for new human proteins has followed a familiar path: read the genetic sequence, predict where genes begin and end, and work outward from there. That strategy has served science remarkably well, delivering the…...

Earth.com
earth.com > science > heart-cells-can-remember-stress-and-use-it-for-protection-during-chemotherapy

Heart cells can ‘remember’ stress and use it for protection during chemotherapy

5+ hour, 26+ min ago   (1157+ words) Early stress in mitochondria before birth helped mouse hearts resist later chemotherapy damage by creating lasting protective changes. Chemotherapy can save lives, but some drugs can also put the heart under serious strain. Doxorubicin, a chemotherapy used against several cancers,…...

BIOENGINEER.ORG
bioengineer.org > daily-step-counts-reveal-frailty-trajectories-in-lung-cancer-patients-during-radiotherapy

Daily Step Counts Reveal Frailty Trajectories in Lung Cancer Patients

1+ hour, 15+ min ago   (76+ words) A new prospective longitudinal study of 327 patients with lung cancer undergoing radiotherapy has found that something as ordinary as a daily step count, captured silently by a smartphone app, can reveal which patients are likely to slip into worsening frailty…...

BIOENGINEER.ORG
bioengineer.org > dual-pi3k-mtor-inhibitor-vdc597-shows-promise-against-canine-lymphoma-and-leukemia-in-lab-studies

Dual PI3K/mTOR Inhibitor VDC597 Shows Promise Against Canine Lymphoma and

1+ hour, 27+ min ago   (732+ words) Lymphoma is one of the most common diagnoses in veterinary oncology, accounting for roughly 7 to 24 percent of all canine cancers and fully 80 percent of hematopoietic tumors in dogs....

BIOENGINEER.ORG
bioengineer.org > protacs-move-from-lab-concept-to-clinical-reality-in-targeted-protein-degradation

PROTACs Move From Lab Concept to Clinical Reality in Targeted Protein

1+ hour, 41+ min ago   (746+ words) A sweeping new review published in Discover Chemistry charts the remarkable rise of proteolysis-targeting chimeras, better known as PROTACs, from a bold theoretical idea to one of the most closely watched platforms in modern drug discovery. Written by Sandip G....